[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":5161000.0,"OtherPrepaidExpenseCurrent_0_Q3_USD":173000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-29000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":7000.0,"OtherAssetsCurrent_0_Q3_USD":303311000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":185000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_3_Q3_USD":133000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":273000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":65000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":202000.0,"OperatingLeaseLiability_0_Q3_USD":267000.0,"OperatingIncomeLoss_3_Q3_USD":-50768000.0,"OperatingIncomeLoss_1_Q3_USD":-19241000.0,"OperatingExpenses_3_Q3_USD":50768000.0,"OperatingExpenses_1_Q3_USD":19241000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-19240000.0,"NetIncomeLossAttributableToRedeemableNoncontrollingInterest_3_Q3_USD":-2109000.0,"NetIncomeLossAttributableToRedeemableNoncontrollingInterest_1_Q3_USD":null,"PaidInKindInterest_3_Q3_USD":19000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"TemporaryEquityDividendsAdjustment_3_Q3_USD":99994000.0,"StockholdersEquity_0_Q3_USD":297672000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_3_Q3_shares":4719605.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_3_Q3_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-105548000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":32395000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":9849000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_3_Q3_USD":8000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":2109000.0,"RedeemablePreferredStockDividends_3_Q3_USD":99994000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":62000.0,"ProfitLoss_3_Q3_USD":-50816000.0,"ProfitLoss_1_Q3_USD":-19240000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_3_Q3_USD":129757000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":167045000.0,"PrepaidInsurance_0_Q3_USD":3332000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":6151000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"RedeemablePreferredStockDividends_1_Q3_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":29859883.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-35370000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":296802000.0,"CommonStockSharesIssued_0_Q3_shares":61928939.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":6972000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashAndCashEquivalentsPeriodIncreaseDecrease_3_Q3_USD":253432000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":297160000.0,"Assets_0_Q3_USD":303783000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":9036632000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":8224000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":5149000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":5149000.0,"AdditionalPaidInCapital_0_Q3_USD":403214000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":31000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":751000.0,"AccruedPayrollTaxesCurrent_0_Q3_USD":1894000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":5161000.0,"AccountsPayableCurrent_0_Q3_USD":683000.0,"CommonStockSharesOutstanding_0_Q3_shares":61928939.0,"DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance_0_Q3_shares":0.0,"DeferredCompensationArrangementWithIndividualSharesIssued_3_Q3_shares":0.0,"DepreciationDepletionAndAmortization_3_Q3_USD":15000.0,"LiabilitiesCurrent_0_Q3_USD":6046000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":303783000.0,"Liabilities_0_Q3_USD":6111000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":14000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":51000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":18000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":212000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":281000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-8000000.0,"InterestExpense_3_Q3_USD":19000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":4808000.0,"IncreaseDecreaseInDepositOtherAssets_3_Q3_USD":31000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":483000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":18373000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":9392000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_3_Q3_USD":0.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-4.98,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.33,"InterestExpense_1_Q3_USD":6000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":57514218.0,"Ticker":"DAWN","CIK":"1845337","name":"DAY ONE BIOPHARMACEUTICALS, INC.","OfficialName":"Day One Biopharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"682620000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211108"}]